GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Panion & BF Biotech 1760.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

49.30

+0.72%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 2.06bn

FY2016FY2025

Net income

TWD 190.2m

FY2016FY2025

Free cash flow

TWD 150.4m

FY2016FY2025

Shareholders' equity

TWD 1.95bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 2.06bnTWD 2.03bnTWD 1.88bnTWD 2.40bnTWD 1.90bnTWD 1.57bnTWD 1.57bnTWD 1.41bnTWD 1.21bnTWD 1.05bn
Gross profitTWD 1.12bnTWD 1.07bnTWD 974.4mTWD 1.32bnTWD 912.1mTWD 814.0mTWD 864.3mTWD 803.4mTWD 694.4mTWD 588.5m
Research and developmentTWD 195.5mTWD 236.9mTWD 217.0mTWD 248.5mTWD 157.7mTWD 127.0mTWD 103.4mTWD 110.7mTWD 103.6mTWD 67.8m
Operating incomeTWD 307.8mTWD 213.3mTWD 156.8mTWD 341.1mTWD 199.4mTWD 97.3mTWD 228.1mTWD 212.0mTWD 144.7mTWD 129.6m
Net incomeTWD 190.2mTWD 124.5mTWD 77.2mTWD 182.3mTWD 104.4mTWD 27.9mTWD 161.3mTWD 159.2mTWD 90.5mTWD 89.7m
Diluted earnings per share2.231.450.902.131.270.382.092.071.321.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.23bnTWD 3.21bnTWD 3.24bnTWD 3.09bnTWD 2.95bnTWD 3.07bnTWD 1.91bnTWD 1.83bnTWD 1.25bnTWD 1.19bn
Cash and short-term investmentsTWD 460.3mTWD 558.4mTWD 534.6mTWD 464.3mTWD 348.9mTWD 406.2mTWD 465.2mTWD 666.4mTWD 221.5mTWD 188.0m
Total liabilitiesTWD 1.27bnTWD 1.29bnTWD 1.32bnTWD 1.09bnTWD 1.02bnTWD 1.83bnTWD 552.9mTWD 484.4mTWD 412.2mTWD 384.8m
DebtTWD 647.7mTWD 704.9mTWD 727.8mTWD 482.3mTWD 502.6mTWD 1.27bnTWD 111.0m———
Shareholders' equityTWD 1.95bnTWD 1.92bnTWD 1.91bnTWD 2.01bnTWD 1.93bnTWD 1.24bnTWD 1.36bnTWD 1.35bnTWD 835.2mTWD 806.4m
Shares outstanding85m86m86m86m83m73m77m77m69m70m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 298.7mTWD 351.2mTWD 177.4mTWD 489.9mTWD 401.2m−TWD 14.6mTWD 91.0mTWD 78.6mTWD 114.0mTWD 177.2m
Capital spending−TWD 148.3m−TWD 185.7m−TWD 181.2m−TWD 198.6m−TWD 170.0m−TWD 101.2m−TWD 82.2m−TWD 39.2m−TWD 25.3m−TWD 77.9m
Free cash flowTWD 150.4mTWD 165.5m−TWD 3.8mTWD 291.2mTWD 231.2m−TWD 115.7mTWD 8.8mTWD 39.4mTWD 88.7mTWD 99.3m
Dividends paid−TWD 154.3m−TWD 128.6m−TWD 171.5m−TWD 128.6m−TWD 53.7m−TWD 138.1m−TWD 138.1m−TWD 115.1m−TWD 55.8m−TWD 45.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 511.8mTWD 519.3mTWD 546.1mTWD 531.9mTWD 503.8mTWD 481.5mTWD 522.5mTWD 501.2m
Gross profitTWD 259.1mTWD 269.4mTWD 285.9mTWD 300.3mTWD 268.6mTWD 262.1mTWD 265.3mTWD 258.9m
Operating incomeTWD 61.9mTWD 83.2mTWD 74.5mTWD 99.5mTWD 79.1mTWD 56.7mTWD 55.6mTWD 58.0m
Net incomeTWD 39.1mTWD 51.7mTWD 48.6mTWD 75.4mTWD 38.0mTWD 28.2mTWD 32.8mTWD 27.7m
Diluted earnings per share0.460.600.570.880.440.330.380.32
Cash from operationsTWD 83.0mTWD 51.0mTWD 124.0mTWD 73.0mTWD 76.0mTWD 33.0mTWD 129.0mTWD 61.0m
Capital spending−TWD 48.0m−TWD 34.0m−TWD 32.0m−TWD 29.0m−TWD 47.0m−TWD 39.0m−TWD 26.0m−TWD 34.0m
Free cash flowTWD 35.0mTWD 17.0mTWD 92.0mTWD 44.0mTWD 29.0m−TWD 6.0mTWD 103.0mTWD 27.0m
Total assetsTWD 3.22bnTWD 3.21bnTWD 3.23bnTWD 3.12bnTWD 3.20bnTWD 3.16bnTWD 3.21bnTWD 3.14bn
Cash and short-term investmentsTWD 471.4mTWD 451.6mTWD 460.3mTWD 380.0mTWD 522.2mTWD 505.1mTWD 558.4mTWD 442.7m
DebtTWD 477.8mTWD 597.5mTWD 640.6mTWD 615.9mTWD 637.8mTWD 646.7mTWD 696.6mTWD 690.2m
Shareholders' equityTWD 1.87bnTWD 1.84bnTWD 1.95bnTWD 1.90bnTWD 1.82bnTWD 1.80bnTWD 1.92bnTWD 1.88bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin54.1%52.7%51.8%55.0%48.0%51.9%
Operating margin14.9%11.9%8.3%14.2%10.5%6.2%
Net margin9.2%6.1%4.1%7.6%5.5%1.8%
Return on equity9.7%6.5%4.0%9.1%5.4%2.3%
Return on assets5.9%3.9%2.4%5.9%3.5%0.9%
Free cash flow yield9.7%11.6%7.8%14.9%12.9%2.2%
Revenue growth1.7%7.9%-21.5%26.2%21.2%-0.3%
Earnings growth52.7%61.3%-57.7%74.7%274.2%-82.7%
Current ratio1.45x1.47x1.41x1.52x1.72x1.54x
Debt to equity0.32x0.36x0.37x0.22x0.23x0.96x
Equity ratio60.6%59.9%59.1%64.9%65.5%40.3%
Interest coverage21.46x16.04x13.81x44.97x13.58x21.80x
R&D as a share of sales9.5%11.7%11.5%10.4%8.3%8.1%
Buybacks as a share of market value0.4%0.1%-0.1%-3.9%-13.0%5.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.9%5.6%5.5%
Operating income-3.4%25.9%9.9%
Net income1.4%46.8%10.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin53.4%53.5%52.4%54.1%
Operating margin12.7%12.2%11.1%11.8%
Net margin7.7%6.9%6.0%7.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings28.356.5124.484.259.4222.841.140.356.456.5
Price to sales2.63.55.16.43.34.04.24.54.24.8

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 12 Jun 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year1.801.502.001.500.1961.6891.7290.982
  • 1.1-for-1 split · 28 Aug 2014
  • 1.15-for-1 split · 6 Jul 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.